Galderma Group AG (GALDY)
42.84
+0.35
(+0.82%)
USD |
OTCM |
Aug 25, 16:00
Galderma Group Market Cap : 49.95B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 49.95B |
| August 24, 2026 | 49.54B |
| August 21, 2026 | 49.91B |
| August 20, 2026 | 49.13B |
| August 19, 2026 | 50.24B |
| August 18, 2026 | 48.54B |
| August 17, 2026 | 48.57B |
| August 14, 2026 | 49.49B |
| August 13, 2026 | 51.22B |
| August 12, 2026 | 50.49B |
| August 11, 2026 | 50.46B |
| August 10, 2026 | 50.42B |
| August 07, 2026 | 52.36B |
| August 06, 2026 | 51.17B |
| August 05, 2026 | 51.32B |
| August 04, 2026 | 50.42B |
| August 03, 2026 | 50.10B |
| July 31, 2026 | 50.84B |
| July 30, 2026 | 52.58B |
| July 29, 2026 | 50.38B |
| July 28, 2026 | 50.43B |
| July 27, 2026 | 49.49B |
| July 24, 2026 | 49.54B |
| July 23, 2026 | 48.39B |
| July 22, 2026 | 49.70B |
| Date | Value |
|---|---|
| July 21, 2026 | 50.26B |
| July 20, 2026 | 49.74B |
| July 17, 2026 | 50.12B |
| July 16, 2026 | 49.14B |
| July 15, 2026 | 48.51B |
| July 14, 2026 | 48.71B |
| July 13, 2026 | 49.07B |
| July 10, 2026 | 50.15B |
| July 09, 2026 | 50.82B |
| July 08, 2026 | 51.02B |
| July 07, 2026 | 51.14B |
| July 06, 2026 | 51.93B |
| July 02, 2026 | 52.48B |
| July 01, 2026 | 51.80B |
| June 30, 2026 | 53.33B |
| June 29, 2026 | 54.17B |
| June 26, 2026 | 51.43B |
| June 25, 2026 | 51.87B |
| June 24, 2026 | 52.78B |
| June 23, 2026 | 50.92B |
| June 22, 2026 | 50.36B |
| June 18, 2026 | 50.36B |
| June 17, 2026 | 50.75B |
| June 16, 2026 | 50.44B |
| June 15, 2026 | 50.91B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sandoz Group AG | 39.83B |
| Novartis AG | 292.85B |
| Roche Holding AG | 322.79B |
| Addex Therapeutics Ltd. | 3.878M |
| Oculis Holding AG | 800.05M |
Market Cap Related Metrics
| PE Ratio | 58.48 |
| PS Ratio | 8.563 |
| Price to Free Cash Flow | 47.82 |
| Price | 42.84 |
| Earnings Yield | 1.71% |
| Operating PE Ratio | 46.20 |
| Normalized PE Ratio | 54.58 |